TD Asset Management Inc Purchases New Shares in LifeStance Health Group, Inc. $LFST

Key Points

• TD Asset Management Inc has acquired a new stake in LifeStance Health Group, purchasing 150,790 shares valued at approximately $780,000, amidst increasing acquisitions by other institutional investors.
• Major shareholders, including Silversmith Partners and Summit Partners, sold a combined total of over 20 million shares, marking a significant decrease in their ownership positions.
• Analysts have mixed ratings for LifeStance Health Group, with UBS raising its price target to $9.00 while Zacks upgraded the company's rating to "strong-buy", indicating varied confidence in its market performance.

TD Asset Management Inc purchased a new stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 150,790 shares of the company's stock, valued at approximately $780,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Blair William & Co. IL acquired a new stake in LifeStance Health Group during the 2nd quarter valued at $70,000. Public Employees Retirement System of Ohio acquired a new stake in shares of LifeStance Health Group during the second quarter worth $70,000. Park Edge Advisors LLC bought a new position in LifeStance Health Group during the second quarter worth about $52,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in LifeStance Health Group by 1.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 615,652 shares of the company's stock worth $4,100,000 after buying an additional 11,331 shares during the last quarter. Finally, Voleon Capital Management LP bought a new position in LifeStance Health Group during the first quarter worth about $163,000. 85.50% of the stock is owned by institutional investors and hedge funds.

Insider Activity at LifeStance Health Group

In related news, major shareholder Silversmith Partners I. Gp, Llc sold 3,592,357 shares of LifeStance Health Group stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $5.07, for a total transaction of $18,213,249.99. Following the transaction, the insider owned 14,324,197 shares of the company's stock, valued at $72,623,678.79. The trade was a 20.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Summit Partners L. P sold 8,407,643 shares of LifeStance Health Group stock in a transaction that occurred on Monday, August 18th. The shares were sold at an average price of $5.07, for a total value of $42,626,750.01. Following the transaction, the insider directly owned 33,524,715 shares in the company, valued at approximately $169,970,305.05. The trade was a 20.05% decrease in their position. The disclosure for this sale can be found here. Insiders sold 20,407,643 shares of company stock valued at $103,466,750 in the last three months. Corporate insiders own 3.20% of the company's stock.

Analyst Ratings Changes

A number of analysts have recently commented on the company. UBS Group boosted their price target on LifeStance Health Group from $8.50 to $9.00 and gave the company a "buy" rating in a report on Friday, August 8th. Zacks Research upgraded LifeStance Health Group from a "hold" rating to a "strong-buy" rating in a report on Tuesday, October 7th. BTIG Research initiated coverage on LifeStance Health Group in a report on Friday, July 25th. They set a "buy" rating and a $8.00 target price on the stock. Weiss Ratings reiterated a "sell (e+)" rating on shares of LifeStance Health Group in a report on Wednesday, October 8th. Finally, Wall Street Zen lowered LifeStance Health Group from a "buy" rating to a "hold" rating in a research note on Saturday, October 11th. Two analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and two have issued a Sell rating to the company. According to data from MarketBeat, LifeStance Health Group currently has an average rating of "Moderate Buy" and a consensus target price of $8.50.

LifeStance Health Group Stock Down 1.7%

Shares of LFST opened at $5.11 on Thursday. The company has a market capitalization of $1.99 billion, a PE ratio of -102.20 and a beta of 1.17. LifeStance Health Group, Inc. has a 12 month low of $3.74 and a 12 month high of $8.61. The stock's 50-day moving average price is $5.36 and its two-hundred day moving average price is $5.40. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.19.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.02. LifeStance Health Group had a negative return on equity of 1.11% and a negative net margin of 1.23%.The firm had revenue of $345.31 million during the quarter, compared to analyst estimates of $345.05 million. During the same period last year, the company posted ($0.06) EPS. The business's quarterly revenue was up 10.6% on a year-over-year basis. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, analysts anticipate that LifeStance Health Group, Inc. will post -0.18 EPS for the current year.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

Want to see what other hedge funds are holding LFST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.